2026 Global: Covered Stent Market -Competitive Review (2032) report
Description
The 2026 Global: Covered Stent Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
W. L. Gore & Associates, headquartered in Flagstaff, United States, dominates the covered stent market with the Viabahn Endoprosthesis, a PTFE‑covered nitinol stent graft widely used for peripheral arterial disease. The device emphasizes durability and flexibility across tortuous vessels, contributing to Gore’s sustained leadership in endovascular grafts. Becton, Dickinson and Company (BD), based in Franklin Lakes, New Jersey, markets BeGraft covered stents that pair a stent framework with an underlying graft to seal dissections and salvage compromised segments, particularly in the femoropopliteal and iliac territories. Getinge AB, headquartered in Getinge, Sweden, manages the Atrium line of covered‑stent products and supports broad surgical–endovascular solutions, offering iCAST and related grafted platforms that facilitate repair and salvage procedures. Terumo Corporation, located in Tokyo, Japan, expands covered‑stent technology through balloon‑expandable and self‑expanding designs, with a global distribution network that emphasizes precise delivery and long‑term patency.
Jotec GmbH, based in Hechingen, Germany, has a long‑standing portfolio of covered stents and stent grafts addressing carotid and peripheral applications, emphasizing radiopaque markers and deliverability through advanced catheter systems. Lifetech Scientific, headquartered in Shenzhen, China, markets a broad range of vascular devices including ePTFE‑covered stents and stent grafts with regional manufacturing and global distribution networks. Cook Medical, headquartered in Bloomington, Indiana, is a major global supplier of endovascular devices, including balloon‑expandable and self‑expanding covered stents designed for complex lesions, dissections, and redo procedures, backed by comprehensive clinical support and training programs. These manufacturers complement regional players and academic collaborations by advancing materials science, surface engineering, and imaging‑guided implantation.
Boston Scientific, headquartered in Marlborough, Massachusetts, has expanded its vascular platform to include stent graft offerings that complement its broader interventional portfolio, pursuing durable coverage and simplified delivery in challenging anatomy. Medtronic plc, based in Dublin, Ireland, leverages its global scale to advance covered‑stent technology through integration with imaging, navigation, and adjunct therapies, reinforcing its position in peripheral and visceral interventions. AngioDynamics, headquartered in Latham, New York, markets vascular devices including covered stents for peripheral procedures, emphasizing streamlined workflows, cost efficiency, and broad procedural applicability. Collectively, these firms—alongside Gore, BD, Getinge, Terumo, Jotec, Lifetech, Cook Medical, Boston Scientific, Medtronic, and AngioDynamics—shape a market defined by expanding indications, regulatory evolution, and ongoing advances in materials science, surface coatings, and delivery systems that improve patency and resistance to restenosis.
W. L. Gore & Associates, headquartered in Flagstaff, United States, dominates the covered stent market with the Viabahn Endoprosthesis, a PTFE‑covered nitinol stent graft widely used for peripheral arterial disease. The device emphasizes durability and flexibility across tortuous vessels, contributing to Gore’s sustained leadership in endovascular grafts. Becton, Dickinson and Company (BD), based in Franklin Lakes, New Jersey, markets BeGraft covered stents that pair a stent framework with an underlying graft to seal dissections and salvage compromised segments, particularly in the femoropopliteal and iliac territories. Getinge AB, headquartered in Getinge, Sweden, manages the Atrium line of covered‑stent products and supports broad surgical–endovascular solutions, offering iCAST and related grafted platforms that facilitate repair and salvage procedures. Terumo Corporation, located in Tokyo, Japan, expands covered‑stent technology through balloon‑expandable and self‑expanding designs, with a global distribution network that emphasizes precise delivery and long‑term patency.
Jotec GmbH, based in Hechingen, Germany, has a long‑standing portfolio of covered stents and stent grafts addressing carotid and peripheral applications, emphasizing radiopaque markers and deliverability through advanced catheter systems. Lifetech Scientific, headquartered in Shenzhen, China, markets a broad range of vascular devices including ePTFE‑covered stents and stent grafts with regional manufacturing and global distribution networks. Cook Medical, headquartered in Bloomington, Indiana, is a major global supplier of endovascular devices, including balloon‑expandable and self‑expanding covered stents designed for complex lesions, dissections, and redo procedures, backed by comprehensive clinical support and training programs. These manufacturers complement regional players and academic collaborations by advancing materials science, surface engineering, and imaging‑guided implantation.
Boston Scientific, headquartered in Marlborough, Massachusetts, has expanded its vascular platform to include stent graft offerings that complement its broader interventional portfolio, pursuing durable coverage and simplified delivery in challenging anatomy. Medtronic plc, based in Dublin, Ireland, leverages its global scale to advance covered‑stent technology through integration with imaging, navigation, and adjunct therapies, reinforcing its position in peripheral and visceral interventions. AngioDynamics, headquartered in Latham, New York, markets vascular devices including covered stents for peripheral procedures, emphasizing streamlined workflows, cost efficiency, and broad procedural applicability. Collectively, these firms—alongside Gore, BD, Getinge, Terumo, Jotec, Lifetech, Cook Medical, Boston Scientific, Medtronic, and AngioDynamics—shape a market defined by expanding indications, regulatory evolution, and ongoing advances in materials science, surface coatings, and delivery systems that improve patency and resistance to restenosis.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
